SeaTown Holdings’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-192,286
Closed -$13.6M 46
2018
Q2
$13.6M Buy
192,286
+127,286
+196% +$8.99M 1.55% 22
2018
Q1
$4.9M Buy
+65,000
New +$5.17M 0.46% 49
2017
Q3
Sell
-73,000
Closed -$5.17M 59
2017
Q2
$5.17M Buy
+73,000
New +$4.86M 0.72% 36
2017
Q1
Sell
-238,600
Closed -$17.1M 47
2016
Q4
$17.1M Buy
238,600
+174,000
+269% +$12.9M 3.93% 11
2016
Q3
$5.11M Buy
+64,600
New +$5.25M 0.97% 32

Other funds holding GILD

SeaTown Holdings's GILD Position: Q3 2018 in Review

SeaTown Holdings sold out of Gilead Sciences (GILD) in Q3 2018, closing a stake of 192,286 shares — an estimated $13.6M sold.

SeaTown Holdings first reported a position in GILD in Q3 2016 and held it in 5 quarters. The position peaked at $17.1M in Q4 2016. 1,528 funds tracked by Wall St. Rank hold GILD as of Q3 2018.

  • SeaTown Holdings reported no remaining Gilead Sciences position as of Q3 2018 after selling out during the quarter.
  • SeaTown Holdings sold 192,286 Gilead Sciences shares in Q3 2018, an estimated $13.6M.
  • SeaTown Holdings first reported a position in Gilead Sciences in Q3 2016 and held it in 5 quarters.
  • SeaTown Holdings's Gilead Sciences position peaked at $17.1M in Q4 2016.
  • 1,528 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2018.

Based on SeaTown Holdings's 13F filing for Q3 2018, filed 1 Nov 2018.